SOUTH EASTON, Mass., Oct. 14, 2009 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI") and Protein Forest, Inc. ("Protein Forest"), (together "the companies"), today announced that they have entered into a strategic co-marketing/selling and research & development agreement. The companies intend to co-market their respective product lines, including in industry publications, at scientific meetings, on each company's website, through common collaborator studies, and at key industry trade shows. PBI and Protein Forest also intend to explore ways to co-develop new instrumentation, accessories/modules for existing instrumentation, and consumables that combine the protein fractionation/software products of Protein Forest with the extraction and protein digestion enhancement products of PBI.

One of the most significant problems in protein analysis today is the proper preparation of a sample prior to analysis with instruments such as a mass spectrometer. Poor sample preparation can lead to significant issues in the accuracy and reproducibility of proteomic test results. Protein Forest and PBI believe that a combination of their respective patented technology platforms will provide scientists with a seamless, more standardized, and integrated workflow to better address key sample preparation issues routinely encountered in an estimated 10,000 research laboratories working in mass spectrometry proteomics worldwide. The companies further believe that this combination of technologies will offer a degree of standardization in the preparation of samples that has heretofore not been available to the mass spectrometry laboratory.

Dr. Russell Garlick, President and CEO of Protein Forest, said: "Pressure Cycling Technology (PCT) is one of the most cutting-edge technologies that I have encountered working in the development, marketing, and sales of products for the life sciences industry. In addition, PCT's ability to greatly accelerate protein digestion (a key step in the mass spectrometry workflow), and its proven protein extraction capabilities, make it unique among general sample preparation methods available today for many different applications, with one of the most important being mass spectrometry. Furthermore, its automated processing functionality and pre-set test parameters offer a level of consistency and reproducibility that is key to accurate sample preparation for subsequent mass spectrometry analysis."

Mr. Richard T. Schumacher, President, and CEO of PBI commented: "Protein Forest has developed novel, patented products for the rapid and accurate fractionation and enrichment of complex protein mixtures. We believe these products have the ability to enhance the analytical performance and workflow in all protein research laboratories, especially those focused on mass spectrometry and biomarker analysis.